Solentim wins place in Deloitte UK Technology Fast 50
About Solentim
Aaron Figg, Director
Solentim is a life sciences instruments company which enables customers to develop an increased number of new and better biopharmaceuticals by providing practical, innovative solutions to help with the challenges of drug discovery and development.
Commercial stable cell line development for biopharmaceutical production and gene therapy is a high value process which is inherently expensive and historically takes a significant amount of time. Solentim® has established itself over the past eight years as a significant leader and innovator of new products in the cell line development arena.
The Cell Metric® product range of bright field imaging stations has a large global installed base of customers, and is recognised as the leader for documenting proof of clonal origin for Master Cell Banks in IND filings to the medicines regulators.
Solentim’s second product range - an automated single cell cloning system called VIPS™ - combines single cell printing into microtiter plates with whole well imaging for clonality.
We help to optimise workflows
Providing solutions for customers working in cell line development in these areas…
Therapeutic Antibody Production
Customers who need to develop, bank and scale up stable cell lines for producing recombinant therapeutic monoclonal antibodies
Biosimilars and Biobetters
Customers developing stable cell lines which make equivalents (Biosimilars) or improved versions of existing blockbuster therapeutic antibodies where the patent has or will expire shortly
Gene Editing & Cell Engineering
Customers in drug discovery using targeted gene editing to make stable cell lines as cellular reagents for target validation, functional genomics and disease modelling
Gene Therapy & CAR-T
Customers involved in vector development who are making stable producer cell lines for virus production which will then be used to infect target cells
Antibody Discovery
Customers working with hybridomas and B cells to discover novel antibody sequences and produce diversity of antibodies. These groups may also be involved in the development of diagnostic antibodies
JOIN OUR WEBINAR ON
"How a Top-5 Pharma Doubled the Speed of Cell Line Development"
27 November 2018 - Registration now open
Latest News
Solentim Wins Place in Deloitte UK Technology Fast 50
Aaron Figg & Ian Taylor at the Deloitte UK Technology Fast 50 Solentim named as one of the top 50 fastest growing UK technologies companies of
Solentim Wins Two Queen’s Awards for Enterprise
Aaron Figg, Dave Elverd, Mr (Ian) Angus Campbell (Her Majesty’s Lord-Lieutenant of Dorset), Ian Taylor, Sky Jiang Solentim’s business excellence and expertise in cell line development
The changing workflows of cell line development – Quality, not Quantity
Damp weather did little to suppress the energy in the rooms at last week’s 10th Annual BioProcessing Summit in Boston. There were over 1,000 delegates, including many from the US
Technology facilitating single cell cloning to help meet regulatory requirements
Patricia Fitzpatrick Diamond discusses recent technological advances aiding single cell cloning, including Solentim’s VIPS™, in GEN. To meet regulatory standards, recombinant proteins must be produced from a single cell line,
Janssen Pharma to present VIPS data at major conference
Customer data presentation at the Bioprocessing Summit in Boston NEWS - Bournemouth, UK – 30th July, 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce that
Solentim at the Palace
This week, members of Solentim’s management team enjoyed the privileged experience of visiting Buckingham Palace. The invitation to a private reception at the Palace followed Solentim’s success in winning two
Conference Report on latest trends in Cell Line Development and Cell Culture
A summary of the Informa Cell Line Development & Engineering conference, held in Amsterdam in April 2018. April 23rd-25th, 2018 Amsterdam: I recently attended the annual Informa Cell Line Development &
Solentim awarded two Queen’s Awards for Enterprise
Solentim, based in Bournemouth, Dorset, is delighted to have been given awards for both International Trade and Innovation. PRESS RELEASE - 21st April, 2018, BOURNEMOUTH: Dorset-based Solentim awarded two Queen’s Awards
Clonality webinar draws a crowd
“Higher confidence of clonality” theme resonates with customers NEWS - Bournemouth, UK – 10th April 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, successfully hosted an educational
Solentim report another record year
Sales Growth Soars to over 80% for 2016 NEWS - Bournemouth, UK – 12th January 2017: Solentim, the leader in Cell Line Development instrumentation, announce another record year of sales. "We